TY - JOUR
T1 - Shwachman–Diamond syndrome
T2 - Nationwide survey and systematic review in Japan
AU - Ikuse, Tamaki
AU - Kudo, Takahiro
AU - Arai, Katsuhiro
AU - Fujii, Yoshimitsu
AU - Ida, Shinobu
AU - Ishii, Tomohiro
AU - Mushiake, Sotaro
AU - Nagata, Kouji
AU - Tamai, Hiroshi
AU - Toki, Akira
AU - Tomomasa, Takeshi
AU - Ushijima, Kosuke
AU - Yanagi, Tadahiro
AU - Yonekura, Takeo
AU - Taguchi, Tomoaki
AU - Shimizu, Toshiaki
N1 - Funding Information:
1Study Group for Rare and Intractable Chronic Gastrointestinal Diseases supported by Health Labour Sciences Research Grant, Ministry of Health Labour and Welfare; 2Department of Pediatrics, Juntendo University Faculty of Medicine, 3Division of Gastroenterology, National Center for Child Health and Development, 4Division of Pediatric Surgery, Department of Surgery, Showa University School of Medicine, Tokyo, 5Division of Pediatrics, Department of Medicine, Tohoku Medical and Pharmaceutical University, Miyagi, 6Osaka Women’s and Children’s Hospital, 7Department of Pediatrics, Osaka Medical College, Osaka, Departments of 8Pediatric Surgery and 9Pediatrics, Kindai University Nara Hospital, Nara, 10Department of Pediatric Surgery, Graduate School of Medical Sciences, Kyushu University, 11Children’s Medical Center, Kyushu University Hospital, 12Department of Pediatrics and Child Health, Kurume University School of Medicine, Fukuoka and 13PAL Children’s Clinic, Gunma, Japan
Publisher Copyright:
© 2018 Japan Pediatric Society
PY - 2018/8
Y1 - 2018/8
N2 - Background: Shwachman–Diamond syndrome (SDS) is a rare multisystem disorder associated with exocrine pancreatic insufficiency. The present study reports the results of a nationwide survey and a systematic review on SDS to develop consensus guidelines for intractable diarrhea including SDS. Methods: Questionnaires were sent to 616 departments of pediatrics or of pediatric surgery in Japan in a nationwide survey. A second questionnaire was sent to doctors who had treated SDS patients and included questions on clinical information. Additionally, a systematic review was performed using digital literature databases to assess the influence of medical (i.e. non-surgical) treatment on SDS prognosis. Results: Answers were received from 529 institutions (85.9%), which included information on 24 patients with SDS (median age, 10.4 years; male, n = 15) treated from January 2005 to December 2014. Although 75% of patients received pancreatic enzyme replacement therapy, there was no significant association between treatment and prognosis. Systematic review identified one clinical practice guideline, two case series, eight case reports and 26 reviews. Patient information from those studies was insufficient for meta-analysis. Conclusions: The rarity of SDS makes it difficult to establish evidence-based treatment for SDS. According to the limited information from patients and published reports, medical treatment for malabsorption due to SDS should be performed to improve fat absorption and stool condition, but it is not clear whether this treatment improves the prognosis of malabsorption.
AB - Background: Shwachman–Diamond syndrome (SDS) is a rare multisystem disorder associated with exocrine pancreatic insufficiency. The present study reports the results of a nationwide survey and a systematic review on SDS to develop consensus guidelines for intractable diarrhea including SDS. Methods: Questionnaires were sent to 616 departments of pediatrics or of pediatric surgery in Japan in a nationwide survey. A second questionnaire was sent to doctors who had treated SDS patients and included questions on clinical information. Additionally, a systematic review was performed using digital literature databases to assess the influence of medical (i.e. non-surgical) treatment on SDS prognosis. Results: Answers were received from 529 institutions (85.9%), which included information on 24 patients with SDS (median age, 10.4 years; male, n = 15) treated from January 2005 to December 2014. Although 75% of patients received pancreatic enzyme replacement therapy, there was no significant association between treatment and prognosis. Systematic review identified one clinical practice guideline, two case series, eight case reports and 26 reviews. Patient information from those studies was insufficient for meta-analysis. Conclusions: The rarity of SDS makes it difficult to establish evidence-based treatment for SDS. According to the limited information from patients and published reports, medical treatment for malabsorption due to SDS should be performed to improve fat absorption and stool condition, but it is not clear whether this treatment improves the prognosis of malabsorption.
UR - http://www.scopus.com/inward/record.url?scp=85050697477&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85050697477&partnerID=8YFLogxK
U2 - 10.1111/ped.13601
DO - 10.1111/ped.13601
M3 - Article
C2 - 29804317
AN - SCOPUS:85050697477
SN - 1328-8067
VL - 60
SP - 719
EP - 726
JO - Pediatrics International
JF - Pediatrics International
IS - 8
ER -